These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1838564)

  • 1. Superoxide dismutase in low-dose-streptozocin-treated mice. A dynamic time-course study.
    Papaccio G; Latronico M; Frascatore S; Pisanti FA
    Int J Pancreatol; 1991; 10(3-4):253-60. PubMed ID: 1838564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increase in superoxide dismutase counteracts islet vascular alterations in low-dose streptozocin-treated mice.
    Papaccio G; Frascatore S; Pisanti FA
    Histochemistry; 1994 Mar; 101(3):215-21. PubMed ID: 8056621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early macrophage infiltration in mice treated with low-dose streptozocin decreases islet superoxide dismutase levels: prevention by silica pretreatment.
    Papaccio G; Frascatore S; Esposito V; Pisanti FA
    Acta Anat (Basel); 1991; 142(2):141-6. PubMed ID: 1664165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vitamin-E derivative U-83836-E in the low-dose streptozocin- treated mouse: effects on diabetes development.
    Papaccio G; Baccari GC; Frascatore S; Sellitti S; Pisanti FA
    Diabetes Res Clin Pract; 1995 Dec; 30(3):163-71. PubMed ID: 8861455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of islet microvasculature in mice treated with low-dose streptozocin.
    Papaccio G; Chieffi-Baccari G
    Histochemistry; 1992 May; 97(4):371-4. PubMed ID: 1535618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetyl-homocysteine-thiolactone-induced increase of superoxide dismutase counteracts the effect of subdiabetogenic doses of streptozocin.
    Papaccio G; Pisanti FA; Frascatore S
    Diabetes; 1986 Apr; 35(4):470-4. PubMed ID: 2937674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide dismutase activity in the BB rat: a dynamic time-course study.
    Pisanti FA; Frascatore S; Papaccio G
    Life Sci; 1988; 43(20):1625-32. PubMed ID: 3057304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of low dose streptozotocin-induced diabetes by acetyl-homocysteine-thiolactone.
    Papaccio G
    Diabetes Res Clin Pract; 1991 Aug; 13(1-2):95-102. PubMed ID: 1773719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas.
    Coskun O; Ocakci A; Bayraktaroglu T; Kanter M
    Tohoku J Exp Med; 2004 Jul; 203(3):145-54. PubMed ID: 15240923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and application of the model of islet impaired by NO free radical released from streptozotocin].
    Qian FY; Ouyang F; Fu DX; Ren TR
    Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):349-52. PubMed ID: 15969020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangliosides prevent insulitis but not islet B cell destruction in low-dose streptozocin-treated mice.
    Papaccio G
    Diabetes Res Clin Pract; 1993 Jan; 19(1):9-15. PubMed ID: 8472624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against streptozotocin-induced diabetes by superoxide dismutase.
    Robbins MJ; Sharp RA; Slonim AE; Burr IM
    Diabetologia; 1980 Jan; 18(1):55-8. PubMed ID: 6444904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase reduces islet microvascular injury induced by streptozotocin in the rat.
    Enghofer M; Usadel KH; Beck O; Kusterer K
    Am J Physiol; 1997 Aug; 273(2 Pt 1):E376-82. PubMed ID: 9277392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.
    Weide LG; Lacy PE
    Diabetes; 1991 Sep; 40(9):1157-62. PubMed ID: 1834505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of islet superoxide dismutase by diabetogenic drugs.
    Crouch RK; Gandy SE; Kimsey G; Galbraith RA; Galbraith GM; Buse MG
    Diabetes; 1981 Mar; 30(3):235-41. PubMed ID: 6451462
    [No Abstract]   [Full Text] [Related]  

  • 16. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
    Wang Z; Gleichmann H
    Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats.
    Bhattacharya SK; Satyan KS; Chakrabarti A
    Indian J Exp Biol; 1997 Mar; 35(3):297-9. PubMed ID: 9332177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of triterpenic acid from Prunella vulgaris L. on glycemia and pancreas in rat model of streptozotozin diabetes.
    Zhou QX; Liu F; Zhang JS; Lu JG; Gu ZL; Gu GX
    Chin Med J (Engl); 2013; 126(9):1647-53. PubMed ID: 23652045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse.
    Vallera DA; Carroll SF; Brief S; Blazar BR
    Diabetes; 1992 Apr; 41(4):457-64. PubMed ID: 1376702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.